London, United Kingdom – 13 July 2026
The Autoimmune Support & Awareness Foundation (ASA Foundation) today announced the launch of ASAL (Autoimmune Symptom Awareness and Learning), an innovative digital health platform believed to be among the world's most comprehensive autoimmune awareness platforms.
Developed to address one of healthcare's greatest challenges—the delayed recognition of autoimmune disease—ASAL empowers individuals to better understand unexplained symptoms, supports healthcare professionals with structured clinical information, and contributes to future autoimmune research through anonymised, consent-based data analysis.
Autoimmune diseases affect an estimated one in ten people, yet many individuals spend years seeking answers before receiving appropriate investigations or a diagnosis. During this time, irreversible damage to organs and tissues can occur, leading to significant physical, emotional and economic...
